XML 117 R58.htm IDEA: XBRL DOCUMENT

BUSINESS SEGMENT INFORMATION (Segment Capital Expenditures and Depreciation) (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Segment Reporting Information [Line Items]
Depreciation	$ 448	$ 473	$ 469
Biopharmaceuticals Segment [Member]
Segment Reporting Information [Line Items]
Capital expenditures	367	424	634
Depreciation	$ 373	$ 380	$ 346

The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.

+ References+ Details